Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers

Journal of Pharmaceutical Sciences
Ho Lun WongXiao Yu Wu

Abstract

The purpose of this study was to develop and characterize a solid lipid nanoparticle (SLN) system containing an anionic polymer for the delivery of cationic antineoplastic agents and chemosensitizers. Ionic complexation was utilized to enhance the loading of these highly water-soluble drugs. The influence of anionic compounds and polymers on drug partition and loading into SLNs was investigated, and dextran sulfate (DS) was found to be the most suitable among those studied. SLNs loaded with doxorubicin and various model chemosensitizers (e.g., verapamil) were thus prepared by incorporating DS using a microemulsion method. The particle size was measured with photon correlation spectroscopy. The mean diameter of the SLNs ranged from 180 to 300 nm, depending on the type and content of the drug and the polymer. The particles possessed weakly negative surface charges as determined by zeta potential measurements. Most polymer-loaded SLNs released half of the drug in the first a few hours and the remaining drug in 15 h or more. The presence of counterions in the medium, especially divalent ions, promoted drug release. Dual drug (doxorubicin/verapamil or quinidine/verapamil)-loaded DS-SLNs were also formulated, which released both drug...Continue Reading

References

Jan 1, 1996·Cancer Chemotherapy and Pharmacology·A G EllisL K Webster
Apr 20, 2001·Advanced Drug Delivery Reviews·W Mehnert, K Mäder
Dec 6, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·Z LiuA M Rauth
Jun 13, 2002·Il Farmaco·E TeodoriF Gualtieri
Jul 24, 2002·Archives of Pharmacal Research·Chong-Kook Kim, Soo-Jeong Lim
Aug 15, 2002·International Journal of Pharmaceutics·R H MüllerS A Wissing

❮ Previous
Next ❯

Citations

Mar 30, 2010·Acta Pharmacologica Sinica·Jian LiYun-feng Wang
May 17, 2006·Clinical and Experimental Pharmacology & Physiology·Yi-Yan YangPeggy Chan
May 9, 2008·Journal of Nanobiotechnology·Débora B Vieira, Ana M Carmona-Ribeiro
Oct 22, 2011·Cellular and Molecular Life Sciences : CMLS·Paul GalvinRonan MacLoughlin
Apr 1, 2012·Drug Delivery and Translational Research·Preethy PrasadXiao Yu Wu
Jul 31, 2013·Drug Delivery and Translational Research·Lipa ShahMansoor Amiji
Mar 24, 2012·Expert Opinion on Drug Delivery·Luigi Battaglia, Marina Gallarate
Jan 14, 2011·Expert Opinion on Drug Delivery·Hongbin ZhangHuai Yang
Aug 8, 2014·Journal of Drug Targeting·Vimratjeet KaurAmit K Goyal
Jan 15, 2016·Colloids and Surfaces. B, Biointerfaces·Mariana S OliveiraLucas A M Ferreira
Mar 26, 2011·Journal of Pharmaceutical Sciences·Dima AlukdaBi-Botti C Youan
Sep 20, 2007·Journal of Pharmaceutical Sciences·Weilun KeYuanying Pei
Nov 28, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Samuel Vidal MussiLucas Antônio Miranda Ferreira
Nov 22, 2011·Advanced Drug Delivery Reviews·Ho Lun WongReina Bendayan
Sep 22, 2010·International Journal of Pharmaceutics·Swati A GuhagarkarPadma V Devarajan
Oct 16, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joanna KopeckaChiara Riganti
Jul 17, 2010·Journal of Pharmaceutical and Biomedical Analysis·Franciane Marquele-OliveiraRenata Fonseca Vianna Lopez
Nov 17, 2009·Advanced Drug Delivery Reviews·Ho Lun WongReina Bendayan
Jul 14, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jhi-Joung WangJia-You Fang
Oct 1, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Medha D Joshi, Rainer H Müller
Apr 15, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yongqiang LiXiao Yu Wu
Jun 22, 2007·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Kaisa HänninenJouni Hirvonen
Jul 31, 2013·Journal of Biomedical Materials Research. Part a·Ehsan AboutalebRassoul Dinarvand
Dec 13, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Ho Lun WongXiao Yu Wu
Nov 14, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ho Lun WongXiao Yu Wu
Mar 16, 2016·Expert Opinion on Drug Delivery·Xiao Yu Wu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.